Page 108 - Williams Hematology ( PDFDrive )

84 Part II: The Organization of the Lymphohematopoietic Tissues

551. Wilson A, Laurenti E, Oser G, et al: Hematopoietic stem cells reversibly switch from 578. Roussel MF, Theodoras AM, Pagano M, Sherr CJ: Rescue of defective mitogenic signal-
dormancy to self-renewal during homeostasis and repair. Cell 135:1118, 2008. ing by D-type cyclins. Proc Natl Acad Sci U S A 92:6837, 1995.
552. Cheshier SH, Prohaska SS, Weissman IL: The effect of bleeding on hematopoietic stem 579. Oguro H, Iwama A: Life and death in hematopoietic stem cells. Curr Opin Immunol
cell cycling and self-renewal. Stem Cells Dev 16:707, 2007. 19:503, 2007.
553. Nervi B, Link DC, DiPersio JF: Cytokines and hematopoietic stem cell mobilization. 580. Berthet C, Rodriguez-Galan MC, Hodge DL, et al: Hematopoiesis and thymic apoptosis
J Cell Biochem 99:690, 2006. are not affected by the loss of Cdk2. Mol Cell Biol 27:5079, 2007.
554. Petit I, Szyper-Kravitz M, Nagler A, et al: G-CSF induces stem cell mobilization by 581. Koury MJ: Programmed cell death (apoptosis) in hematopoiesis. Exp Hematol 20:391,
decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 3:687, 2002. 1992.
555. Christopher MJ, Liu F, Hilton MJ, et al: Suppression of CXCL12 production by bone 582. Kelley LL, Koury MJ, Bondurant MC, et al: Survival or death of individual proerythrob-
marrow osteoblasts is a common and critical pathway for cytokine-induced mobiliza- lasts results from differing erythropoietin sensitivities: A mechanism for controlled
tion. Blood 114:1331, 2009. rates of erythrocyte production. Blood 82:2340, 1993.
556. Levesque J-P, Liu F, Simmons PJ, et al: Characterization of hematopoietic progenitor 583. Opferman JT: Life and death during hematopoietic differentiation. Curr Opin Immunol
mobilization in protease-deficient mice. Blood 104:65, 2004. 19:497, 2007.
557. Semerad CL, Christopher MJ, Liu F, et al: G-CSF potently inhibits osteoblast activity 584. Reed JC: Bcl-2-family proteins and hematologic malignancies: History and future pros-
and CXCL12 mRNA expression in the bone marrow. Blood 106:3020, 2005. pects. Blood 111:3322, 2008.
558. Christopher MJ, Link DC: Granulocyte colony-stimulating factor induces osteoblast 585. Llambi F, Green DR: Apoptosis and oncogenesis: Give and take in the BCL-2 family.
apoptosis and inhibits osteoblast differentiation. J Bone Miner Res 23:1765, 2008. Curr Opin Genet Dev 21:12, 2011.
559. Papayannopoulou T, Priestley GV, Nakamoto B, et al: Synergistic mobilization of 586. Kaisho T, Ishikawa J, Oritani K, et al: BST-1, a surface molecule of bone marrow stromal
hemopoietic progenitor cells using concurrent beta1 and beta2 integrin blockade or cell lines that facilitates pre-B-cell growth. Proc Natl Acad Sci U S A 91:5325, 1994.
beta2-deficient mice. Blood 97:1282, 2001. 587. Opferman JT, Iwasaki H, Ong CC, et al: Obligate role of anti-apoptotic MCL-1 in the
560. Velders GA, Pruijt JFM, Verzaal P, et al: Enhancement of G-CSF-induced stem cell survival of hematopoietic stem cells. Science 307:1101, 2005.
mobilization by antibodies against the beta 2 integrins LFA-1 and Mac-1. Blood 588. Hamasaki A, Sendo F, Nakayama K, et al: Accelerated neutrophil apoptosis in mice
100:327, 2002. lacking A1-a, a subtype of the bcl-2-related A1 gene. J Exp Med 188:1985, 1998.
561. Ramirez P, Rettig MP, Uy GL, et al: BIO5192, a small molecule inhibitor of VLA-4, 589. Rhodes MM, Kopsombut P, Bondurant MC, et al: Bcl-x(L) prevents apoptosis of late-
mobilizes hematopoietic stem and progenitor cells. Blood 114:1340, 2009. stage erythroblasts but does not mediate the antiapoptotic effect of erythropoietin.
562. Leone DR, Giza K, Gill A, et al: An assessment of the mechanistic differences between Blood 106:1857, 2005.
two integrin α4β1 inhibitors, the monoclonal antibody TA-2 and the small molecule 590. Aerbajinai W, Giattina M, Lee YT, et al: The proapoptotic factor Nix is coexpressed with
BIO5192, in rat experimental autoimmune encephalomyelitis. J Pharmacol Exp Ther Bcl-xL during terminal erythroid differentiation. Blood 102:712, 2003.
305:1150, 2003. 591. von Lindern M, Schmidt U, Beug H: Control of erythropoiesis by erythropoietin and
563. Pruijt JFM, Verzaal P, van Os R, et al: Neutrophils are indispensable for hematopoi- stem cell factor: A novel role for Bruton’s tyrosine kinase. Cell Cycle 3:876, 2004.
etic stem cell mobilization induced by interleukin-8 in mice. Proc Natl Acad Sci U S A 592. Muta K, Krantz SB, Bondurant MC, Wickrema A: Distinct roles of erythropoietin, insu-
99:6228, 2002. lin-like growth factor I, and stem cell factor in the development of erythroid progenitor
564. Bowie MB, Kent DG, Dykstra B, et al: Identification of a new intrinsically timed devel- cells. J Clin Invest 94:34, 1994.
opmental checkpoint that reprograms key hematopoietic stem cell properties. Proc Natl 593. Sandoval H, Thiagarajan P, Dasgupta SK, et al: Essential role for Nix in autophagic mat-
Acad Sci U S A 104:5878, 2007. uration of erythroid cells. Nature 454:232, 2008.
565. Pietras EM, Warr MR, Passegué E: Cell cycle regulation in hematopoietic stem cells. J 594. Schweers RL, Zhang J, Randall MS, et al: NIX is required for programmed mitochon-
Cell Biol 195:709, 2011. drial clearance during reticulocyte maturation. Proc Natl Acad Sci U S A 104:19500,
566. Haylock DN, Williams B, Johnston HM, et al: Hemopoietic stem cells with higher 2007.
hemopoietic potential reside at the bone marrow endosteum. Stem Cells 25:1062, 2007. 595. Finch CA, Harker LA, Cook JD: Kinetics of the formed elements of human blood.
567. Passegué E, Wagers AJ, Giuriato S, et al: Global analysis of proliferation and cell cycle Blood 50:699, 1977.
gene expression in the regulation of hematopoietic stem and progenitor cell fates. J Exp 596. Nagai Y, Garrett KP, Ohta S, et al: Toll-like receptors on hematopoietic progenitor cells
Med 202:1599, 2005. stimulate innate immune system replenishment. Immunity 24:801, 2006.
568. Shapiro HM: Flow cytometric estimation of DNA and RNA content in intact cells 597. Yáñez A, Goodridge HS, Gozalbo D, Gil ML: TLRs control hematopoiesis during infec-
stained with Hoechst 33342 and pyronin Y. Cytometry 2:143, 1981. tion. Eur J Immunol 43:2526, 2013.
569. Dick FA, Rubin SM: Molecular mechanisms underlying RB protein function. Nat Rev 598. Sioud M, Fløisand Y, Forfang L, Lund-Johansen F: Signaling through toll-like receptor
Mol Cell Biol 14:297, 2013. 7/8 induces the differentiation of human bone marrow CD34+ progenitor cells along
570. Walkley CR, Sankaran VG, Orkin SH: Rb and hematopoiesis: Stem cells to anemia. Cell the myeloid lineage. J Mol Biol 364:945, 2006.
Div 3:13, 2008. 599. Hirai H, Zhang P, Dayaram T, et al: C/EBPbeta is required for “emergency” granulo-
571. Narasimha A, Kaulich M, Shapiro G, et al: Cyclin D activates the Rb tumor suppressor poiesis. Nat Immunol 7:732, 2006.
by mono-phosphorylation. Elife 3, 2014. 600. McGettrick AF, O’Neill LAJ: Toll-like receptors: Key activators of leucocytes and regu-
572. Sherr CJ, Roberts JM: Living with or without cyclins and cyclin-dependent kinases. lator of haematopoiesis. Br J Haematol 139:185, 2007.
Genes Dev 18:2699, 2004. 601. Zhao JL, Ma C, O’Connell RM, et al: Conversion of danger signals into cytokine signals
573. Kozar K, Ciemerych MA, Rebel VI, et al: Mouse development and cell proliferation in by hematopoietic stem and progenitor cells for regulation of stress-induced hemato-
the absence of D-cyclins. Cell 118:477, 2004. poiesis. Cell Stem Cell 14:445, 2014.
574. Malumbres M, Sotillo R, Santamaría D, et al: Mammalian cells cycle without the D-type 602. Welner Robert S, Kincade Paul W: 9-1-1: HSCs respond to emergency calls. Cell Stem
cyclin-dependent kinases Cdk4 and Cdk6. Cell 118:493, 2004. Cell 14:415, 2014.
575. Steinman RA: Cell cycle regulators and hematopoiesis. Oncogene 21:3403, 2002. 603. Testa U: Apoptotic mechanisms in the control of erythropoiesis. Leukemia 18:1176,
576. Metcalf D: Hematopoietic cytokines. Blood 111:485, 2008. 2004.
577. Tushinski RJ, Stanley ER: The regulation of mononuclear phagocyte entry into S phase
by the colony stimulating factor CSF-1. J Cell Physiol 122:221, 1985.

Kaushansky_chapter 05_p0051-0084.indd 84 9/19/15 12:11 AM